Kim SH, Macari S, Koller J, Chawarska K. Examining the phenotypic heterogeneity of early autism spectrum disorder: subtypes and short-term outcomes. J Child Psychol Psychiatry. 2016;57(1):93–102.
Lai MC, Lombardo MV, Baron-Cohen S. Autism. The Lancet. 2014;383(9920):896–910.
Bölte S, Girdler S, Marschik PB. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci. 2019;76(7):1275–97.
de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. Advancing the understanding of autism disease mechanisms through genetics. Nat Med. 2016;22(4):345–61.
Article PubMed PubMed Central Google Scholar
Frye RE, Vassall S, Kaur G, Lewis C, Karim M, Rossignol D. Emerging biomarkers in autism spectrum disorder: a systematic review. Ann Transl Med. 2019;7(23):792–792.
Article CAS PubMed PubMed Central Google Scholar
Goldani AAS, Downs SR, Widjaja F, Lawton B, Hendren RL. Biomarkers in autism. Front Psychiatry [Internet]. 2014 [cited 2023 May 31];5. https://doi.org/10.3389/fpsyt.2014.00100
Garcia-Gutierrez E, Narbad A, Rodríguez JM. Autism spectrum disorder associated with gut microbiota at immune, metabolomic, and neuroactive level. Front Neurosci [Internet]. 2020 [cited 2023 Jun 20];14. https://doi.org/10.3389/fnins.2020.578666
Abi-Dargham A, Moeller SJ, Ali F, DeLorenzo C, Domschke K, Horga G, et al. Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry. 2023;22(2):236–62.
Article PubMed PubMed Central Google Scholar
Frye RE, Rossignol DA. Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res. 2011;69(5, Part 2 of 2):41R-47R.
Article CAS PubMed PubMed Central Google Scholar
Goldenthal MJ, Damle S, Sheth S, Shah N, Melvin J, Jethva R, et al. Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. Biomark Med. 2015;9(10):957–65.
Article CAS PubMed Google Scholar
Weissman JR, Kelley RI, Bauman ML, Cohen BH, Murray KF, Mitchell RL, et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS ONE. 2008;3(11):e3815.
Article PubMed PubMed Central Google Scholar
Harris AD, Saleh MG, Edden RAE. Edited 1H magnetic resonance spectroscopy in vivo: methods and metabolites. Magn Reson Med. 2017;77(4):1377–89.
Article CAS PubMed PubMed Central Google Scholar
Patel AB, Lai JCK, Chowdhury GMI, Hyder F, Rothman DL, Shulman RG, et al. Direct evidence for activity-dependent glucose phosphorylation in neurons with implications for the astrocyte-to-neuron lactate shuttle. Proc Natl Acad Sci. 2014;111(14):5385–90.
Article CAS PubMed PubMed Central Google Scholar
Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab. 2008;94(1):16–37.
Article CAS PubMed PubMed Central Google Scholar
El-Hattab AW, Scaglia F. Mitochondrial cytopathies. Cell Calcium. 2016;60(3):199–206.
Article CAS PubMed Google Scholar
Yamada K, Toribe Y, Yanagihara K, Mano T, Akagi M, Suzuki Y. Diagnostic accuracy of blood and CSF lactate in identifying children with mitochondrial diseases affecting the central nervous system. Brain Dev. 2012;34(2):92–7.
Bricout M, Grévent D, Lebre AS, Rio M, Desguerre I, Lonlay PD, et al. Brain imaging in mitochondrial respiratory chain deficiency: combination of brain MRI features as a useful tool for genotype/phenotype correlations. J Med Genet. 2014;51(7):429–35.
Article CAS PubMed Google Scholar
Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, et al. Mitochondrial diseases. Nat Rev Dis Primer. 2016;2(1):1–22.
Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial Reactive Oxygen Species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909–50.
Article CAS PubMed PubMed Central Google Scholar
Meyer JN, Leuthner TC, Luz AL. Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 2017;1(391):42–53.
Finsterer J, Zarrouk MS. Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders. Expert Opin Drug Metab Toxicol. 2012;8(1):71–9.
Article CAS PubMed Google Scholar
Coleman M, Blass JP. Autism and lactic acidosis. J Autism Dev Disord. 1985;15(1):1–8.
Article CAS PubMed Google Scholar
Al-Mosalem OA, El-Ansary A, Attas O, Al-Ayadhi L. Metabolic biomarkers related to energy metabolism in Saudi autistic children. Clin Biochem. 2009;42(10–11):949–57.
Article CAS PubMed Google Scholar
Hassan MH, Desoky T, Sakhr HM, Gabra RH, Bakri AH. Possible metabolic alterations among autistic male children: clinical and biochemical approaches. J Mol Neurosci MN. 2019;67(2):204–16.
Article CAS PubMed Google Scholar
Karim M, Begum S, Shahzadi S. Serum lactate, AST, ALT in male autistic children in Bangladesh. J Bangladesh Soc Physiol. 2016;10(2):56–60.
Oh M, Kim SA, Yoo HJ. Higher lactate level and lactate-to-pyruvate ratio in autism spectrum disorder. Exp Neurobiol. 2020;29(4):314–22.
Article PubMed PubMed Central Google Scholar
Oliveira G, Diogo L, Grazina M, Garcia P, Ataíde A, Marques C, et al. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol. 2005;47(3):185–9.
Article CAS PubMed Google Scholar
Shahjadi S, Khan AS, Ahmed MU. Mitochondrial dysfunction in early diagnosed autism spectrum disorder children. J Dhaka Med Coll. 2017;26(1):43–7.
Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, et al. Mitochondrial dysfunction in autism. JAMA. 2010;304(21):2389–96.
Article CAS PubMed PubMed Central Google Scholar
László A, Horváth E, Eck E, Fekete M. Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin Chim Acta. 1994;229(1):205–7.
Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17(3):290–314.
Article CAS PubMed Google Scholar
Rahman S. Mitochondrial disease and epilepsy. Dev Med Child Neurol. 2012;54(5):397–406.
Tebartz van Elst L, Maier S, Fangmeier T, Endres D, Mueller GT, Nickel K, et al. Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis. Mol Psychiatry. 2014;19(12):1314–25.
Article CAS PubMed Google Scholar
Maier S, Düppers AL, Runge K, Dacko M, Lange T, Fangmeier T, et al. Increased prefrontal GABA concentrations in adults with autism spectrum disorders. Autism Res. 2022;15(7):1222–36.
Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23(4):635–41.
Article CAS PubMed Google Scholar
Hashimoto T, Tayama M, Miyazaki M, Yoneda Y, Yoshimoto T, Harada M, et al. Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. J Child Neurol. 1997;12(2):91–6.
Article CAS PubMed Google Scholar
Friedman SD, Shaw DW, Artru AA, Richards TL, Gardner J, Dawson G, et al. Regional brain chemical alterations in young children with autism spectrum disorder. Neurology. 2003;60(1):100–7.
Article CAS PubMed Google Scholar
Friedman SD, Shaw DWW, Artru AA, Dawson G, Petropoulos H, Dager SR. Gray and white matter brain chemistry in young children with autism. Arch Gen Psychiatry. 2006;63(7):786–94.
Article CAS PubMed Google Scholar
Corrigan NM, Shaw Dennis WW, Richards TL, Estes AM, Friedman SD, Petropoulos H, et al. Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. J Autism Dev Disord. 2012;42(1):105–15.
Comments (0)